Active Surveillance for Localized Prostate Cancer

A New Paradigm for Clinical Management

Gebonden Engels 2012 2012e druk 9781617799112
Verwachte levertijd ongeveer 9 werkdagen

Samenvatting

Active Surveillance for Localized Prostate Cancer: A New Paradigm for Clinical Management will serve as a useful resource for physicians dealing with, and interested in, this complex and evolving branch of prostate cancer management.  The book will also be of interest to scientifically literate patients and their families.   The volume provides an introduction to the concept of active surveillance in oncology in general and prostate cancer specifically. The primary focus is to provide a comprehensive guide to the management of patients on surveillance. The volume covers the many complexities and nuances to this approach including, patient selection, risk assessment, how to overcome 'cancer hysteria' when counseling patients, identifying appropriate triggers for intervention, use of PSA kinetics and MR imaging information, technique and frequency of biopsies, secondary prevention interventions, and the relative roles of surveillance and focal therapy.

Specificaties

ISBN13:9781617799112
Taal:Engels
Bindwijze:gebonden
Aantal pagina's:208
Uitgever:Humana Press
Druk:2012

Lezersrecensies

Wees de eerste die een lezersrecensie schrijft!

Inhoudsopgave

<p>Chapter 1. The Problem of Cancer Overdiagnosis and Overtreatment<br>by Laurence Klotz<br>Chapter 2. Patient Selection for Active Surveillance<br>by John Eifler and H. Ballentine Carter<br>Chapter 3. Predicting High Risk Disease Using Tissue Biomarkers<br>by Michael J. Donovan and Carlos Cordon-Cardo<br>Chapter 4. Predicting High Risk Disease Using Serum and DNA Biomarkers<br>by Danny Vesprini and Robert Nam<br>Chapter 5. Triggers for Intervention in Men on Surveillance<br>by S.Y. Jackie Sham and Chris Parker<br>Chapter 6. The Role of MRI in Active Surveillance <br>by Caroline M. Moore, Clare Allen, Mark Emberton<br>Chapter 7. Active Surveillance:  The European Experience<br>by Meelan Bul, Monique J. Roobol and Chris H. Bangma <br>Chapter 8. Active Surveillance:  The Canadian Experience<br>by Laurence Klotz<br>Chapter 9. Psychosocial Aspects of Active Surveillance<br>by Meredith Wallace Kazer, Dwanna M. Ward-Boahen, David M. Latini, Donald E. Bailey, Jr.<br>Chapter 10. Statistical Considerations for Patient Selection and Triggers for Intervention in Active Surveillance<br>by Andrew J. Vickers<br>Chapter 11. Interpreting PSA Kinetics using GLMM Technique<br>by Liying Zhang and Laurence Klotz<br>Chapter 12. The Potential Benefits of Diet and Physical Activity among Active Surveillance Patients with Low-Burden Prostate Cancer<br>by Stacey A. Kenfield, J. Kellogg Parsons, June M. Chan<br>Chapter 13. The Role of 5α-Reductase Inhibitors (5-ARIs) in Expectant Management of Low Risk Prostate Cancer <br>by David Margel and Neil Fleshner<br>Chapter 14. Urologists’ Opinion on Active Surveillance: United States vs. the Netherlands <br>by Lionne D.F. Venderbos, Chris H. Bangma, Ida J. Korfage <br>Chapter 15. Clinical ‘Pearls’ in Managing Patients on Surveillance<br>by Laurence Klotz<br>Chapter 16. Active Surveillance, Focal Therapy and the Future<br>by Mark Emberton<br />Chapter 17. The Economics of Active Surveillance for Prostate Cancer<br>by Marc A. Dall’Era and Christopher P. Evans<br>Chapter 18. The Future of Active Surveillance<br>by Sima P. Porten, Jared M. Whitson, Peter R. Carroll</p><p>

Managementboek Top 100

Rubrieken

    Personen

      Trefwoorden

        Active Surveillance for Localized Prostate Cancer